top


PDF Print E-mail

XOventure is founder or co-founder of several companies and/or subsidiaries, e.g.:

  • ViroGates
  • Alsensa
  • www.yourglobaleye.com
  • Immudex
  • Innovation Circus

The process may seem generic, however the wrong chain of events, partners or strategy has proven to postpone success and increase cost substantially. Also, a set of templates and structures that we have developed and refined over years of practice are a huge acceleration: "Plug and play" rather then spend time re-inventing systems and  learning simple things by trial and error.

AND... our strength is to invest in ideas that anticipate the future market's needs and trends. Every 5 years a major tipping point for mega-trends occurs, below the major trend-tippers in the life science industry:

 

Year 2010:
The era of personalized
medicine & biomarker
s

 

 

 

 

 

 

 

Last Updated on Monday, 14 February 2011 14:48
 

News

COURSE
Drug Development:
Challenges & Solutions
May 23-25, 2011, Copenhagen
Pathology Experts
in collaboration with XOventure
More information
_____________
XOventure opens
new Copenhagen office:
Bagsværdvej 70A
DK-2800 Lyngby
Opening Reception
Feb 4, 2011
_____________
Managing Partner
Jørgen Thorball
receives Medicon Valley
Cross-Border Award
Oct 28, 2010
ReadXOventure GmbH established in Lucerne, central Switzerland!

 

Dec 2011:
2nd Drug Development Course

Registration open!
Pathology Experts & XOventure.
More Information 


Nov 2011: 
Entrepreneur of the Year

Immudex, a management buy-out from Dako led by XO win Ernst & Young's "Entrepreneur of the Year" 2011!


July 2011: XOventure GmbH 
XOventure GmbH established in Lucerne, central Switzerland!   


May 2011:
Success with course!
 
 
Drug Development: 
Challenges & Solutions 
Pathology Experts & XOventure.



bottom

Powered by Joomla!. Designed by: Joomla 1.5 Template, web space. Valid XHTML and CSS.